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ABSTRACT
Transfer RNA (tRNA) contains a number of complex
‘hypermodified’ nucleosides that are essential for a
number of genetic processes. Intermediate forms of
these nucleosides are rarely found in tRNA despite
the fact that modification is not generally a complete
process. We propose that the modification machin-
ery is tuned into an efficient ‘assembly line’ that
performs the modification steps at similar, or se-
quentially increasing, rates to avoid build-up of
possibly deleterious intermediates. To investigate
this concept, we measured steady-state kinetics
for the final two steps of the biosynthesis of the
mnm
5s
2U nucleoside in Escherichia coli tRNA
Glu,
which are both catalysed by the bifunctional MnmC
enzyme. High-performance liquid chromatography-
based assays using selectively under-modified tRNA
substrates gave a Km value of 600nM and kcat
0.34s
 1 for the first step, and Km 70nM and kcat
0.31s
 1 for the second step. These values show
that the second reaction occurs faster than the first
reaction, or at a similar rate at very high substrate
concentrations. This result indicates that the
enzyme is kinetically tuned to produce fully
modified mnm
5(s
2)U while avoiding build-up of the
nm
5(s
2)U intermediate. The assay method developed
here represents a general approach for the com-
parative analysis of tRNA-modifying enzymes.
INTRODUCTION
tRNA molecules are heavily modiﬁed with many
non-canonical nucleosides, which perform a number of
biological functions including structural stabilization (1)
and optimization of codon binding (2). These modiﬁca-
tions range from simple methylations to complex
‘hypermodiﬁed’ residues involving multistep biosyntheses.
The hypermodiﬁed nucleosides are particularly interest-
ing, as the cellular machinery allocates a relatively large
amount of energy to the biosyntheses of these modiﬁca-
tions, indicating a high importance to cellular processes.
These nucleosides are most often located in or adjacent to
the anticodon (3), and are involved in key translation
processes anticodon–stem loop stabilization (2), codon
binding and wobble base pairing (4,5). Recent studies on
the quantiﬁcation of modiﬁed nucleosides show that
tRNA is not always fully modiﬁed, instead containing a
signiﬁcant number of unmodiﬁed positions [(6,7) and un-
published data]. However, partially modiﬁed precursors of
hypermodiﬁed nucleosides are generally not observed,
with the exception of those present in tRNAs that
always contain the partially modiﬁed form (3,8–10).
Together, these results suggest that biosynthetic
pathways are organized to give complete hypermodiﬁed
nucleosides, avoiding partially modiﬁed intermediate nu-
cleosides. Biosynthetic tuning of this type would require a
coordinated ‘assembly line’ process in which sequential
modiﬁcations are performed at similar, or increasing,
rates in order to efﬁciently construct the ﬁnal products
without a build-up of intermediates. We propose that
this process is likely to be predominantly controlled by
tuning of the activities and abundances of the tRNA-
modifying proteins. Alternatively, biosynthetic tuning
could involve selective degradation of partially modiﬁed
tRNAs (11) or control of enzyme compartmentalization
(12) in eukaryotes.
The 5-methylaminomethyl(-2-thio)uridine (mnm
5(s
2)U)
residue, which is present in position 34 of the anticodon of
Escherichia coli tRNAs Glu, Lys, Arg and, probably, Gln
(3), is particularly interesting due to its involvement in
wobble base pairing (4,5,13,14) and its complex
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2 group
is inserted by the MnmA enzyme (15,16), while the mnm
5
group is independently formed in a three-step sequence.
Initially, (s
2)U is converted to
5-carboxymethylaminomethyl(-2-thio)uridine
(cmnm
5(s
2)U) by a two-enzyme complex involving
addition of glycine to a reactive intermediate (17–19).
The cmnm
5(s
2)U base is then converted to mnm
5s
2Ui n
two steps by the bifunctional enzyme MnmC (20–22),
which initially carries out a ﬂavin adenine dinucleotide
(FAD)-mediated demodiﬁcation to 5-aminomethyl(-
2-thio)uridine (nm
5(s
2)U), followed by methylation to
mnm
5(s
2)U using S-adenosylmethionine (SAM) as
cofactor. To test our proposal that the modiﬁcation
steps are coordinated by tuning of the kinetics and abun-
dance of biosynthesis enzymes, we investigated the
activities of the two modiﬁcation steps performed by
MnmC. As these two reaction steps are both performed
by a single enzyme, differences in enzyme abundance for
the individual steps are excluded. Therefore, control of
enzyme kinetics would be necessary for our proposed
assembly-line type process. To our knowledge, the
partial modiﬁcation nm
5(s
2)U has not been reported in
normal cellular tRNA, indicating that this intermediate
is avoided by the biosynthetic machinery. The presence
or absence of under-modiﬁed cmnm
5(s
2)U is not clear
due to the natural occurrence of this nucleoside at
certain tRNA positions.
Kinetic assay of complex tRNA-modifying enzymes
is generally problematic due to the difﬁculty of obtain-
ing deﬁned under-modiﬁed tRNA substrates and
the measurement of reaction progress. Previous
cmnm
5(s
2)U!mnm
5(s
2)U assays have used either total
tRNA from cells lacking MnmC (20–22) or substantially
under-modiﬁed tRNA from in vitro transcription (18). The
most accurate assay results to date indicate that the ﬁrst
step is rate limiting (20), but could only measure the
methylation reaction and did not have the deﬁned sub-
strates necessary for full kinetic analysis. In order to
obtain such substrates for reaction with MnmC, we
overexpressed tRNA
Glu in an E. coli expression strain
lacking MnmC, then isolated the selectively under-
modiﬁed cmnm
5s
2U-containing tRNA species using
anion-exchange high-performance liquid chromatography
(HPLC). The second substrate (containing nm
5s
2U) was
formed by reaction of the cmnm
5s
2U-containing tRNA
with MnmC in the absence of the SAM cofactor.
Reaction of each substrate with MnmC was assayed
using anion-exhange HPLC to monitor reaction
progress. To further assess the importance of the
MnmC-mediated modiﬁcations, we additionally
measured growth curves for an MnmC knockout E. coli
strain and its corresponding wild-type strain.
MATERIALS AND METHODS
Preparation of recombinant MnmC protein
His-tagged MnmC was cloned and expressed as previously
reported (21) in E. coli BL21 cells, and puriﬁed as follows.
All steps were performed at 0–4 C. Harvested cells were
suspended in buffer A (50mM Tris–HCl, pH 8.0, 200mM
KCl, 10mM MgCl2,3 m Mb-mercaptoethanol, 10%
glycerol) with the addition of lysozyme (0.2mg/ml), then
lysed using a French press. The lysate was cleared by cen-
trifugation (24000g for 30min) and ﬁltration (0.45mM)
and was applied to a HiScreen IMAC FF column (GE
Healthcare) charged with Ni
2+, using an A ¨ KTApuriﬁer
system (GE Healthcare). The column was washed with
Scheme 1. Biosynthesis of mnm
5(s
2)U in tRNA. X=O (in U) or S (in s
2U), R=cmnm
5,n m
5 or mnm
5. Modiﬁed positions are coloured in red.
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was eluted with buffer A containing 0.5M imidazole. The
protein obtained was concentrated and exchanged into
buffer B (buffer A lacking KCl) using an Amicon Ultra
30000 MWCO centrifugal ﬁlter (Millipore) then applied
to a 1ml Mono Q column (GE Healthcare) equilibrated
with the same buffer. The enzyme was eluted with a linear
gradient of buffer C (buffer A containing 500mM KCl),
concentrated then applied to a Superdex 200 GL10/300
size-exclusion column and eluted with buffer C. The
puriﬁed protein was concentrated to 10mg/ml in buffer
D (buffer A containing only 50mM KCl) and stored at
 80 C. A yield of  10mg of puriﬁed protein was
obtained from 4l of expression culture. Protein concentra-
tion was calculated by Bradford assay.
MnmC knockout from an E. coli expression strain
The MnmC gene was removed from T7 express E. coli
(NEB) by replacement with a chloramphenicol resistance
cassette. The cassette was made by polymerase chain
reaction (PCR) ampliﬁcation of the cmr gene from the
pDEST17 plasmid (Invitrogen) using Phusion polymerase
(Finnzymes) and the following primers, each
incorporating 50 bases of the MnmC gene: 50-TGAAAC
ACTACTC CATACAACCTGCCAACCTCGAATTTA
ATGCTGAGGGTGCGGCCGCATTAGGCACCCC
and 50-TACCCCGCCTTAACCGCTTTACCCTTCAAC
AATTTCCGCACCCATAACC GTTACGCCCCGCCC
TGCCACT. Chemically competent T7 express cells were
transformed with the pSIM6 plasmid (23), kindly supplied
by Donald L. Court, then made electrocompetent and
transformed with the PCR-ampliﬁed Cam cassette. After
pregrowth in LB medium then selection on Cam plates,
several colonies were chosen and conﬁrmed by PCR to
contain the Cam gene and no MnmC gene (primers:
(50-CTGAACCATATGAAACA CTACTCCATACAAC
CTGCC, 50-CTGAACAGATCTTTACCCCGCCTTAA
CCGCTTTA CCCTTCAAC). The cells were made
electrocompetent then stored at  80 C in 10% glycerol.
Cloning, expression and puriﬁcation of
under-modiﬁed tRNA
Glu
The tRNA
Glu gene (corresponding to RNA sequence GU
CCCCUUCGUCUAGAGGCCCA GGACACCGCCCU
UUCACGGCGGUAACAGGGGUUCGAAUCCCCU
AGGGGACGCCA) was ampliﬁed by PCR from NEB5a
E. coli (NEB) using Phusion polymerase and the following
primers to give an EcoRI cleavage site and the T7
promoter 50 of the tRNA sequence, and BsaI and
HindIII cleavage sites 30 of the tRNA: 50-GAATTCTAA
TACGACT CACTATAGTCCCCTTCGTCTAGAGGC
CCAGGA and 50-AAGCTTGGTCTCATGGCGT CCC
CTAGGGGATTCGAACC. The PCR product was
cleaved with the EcoRI and HindIII restriction enzymes,
and ligated into the pSGAT2 plasmid. The presence of the
tRNA
Glu gene was conﬁrmed by sequencing. The expres-
sion plasmid was then used to transform electrocompetent
MnmC T7 express cells (see above). Transformed cells
were grown in LB-medium supplemented with
carbenicillin (100mg/ml) to an OD600 of 0.5, then
induced with 1mM isopropyl b-d-1-thiogalactopyranoside
(IPTG) for 6h and harvested. The cell pellets were phenol
extracted as reported previously (6) to give total cell
tRNA ( 20mg per litre of E. coli culture), which was
dissolved at  10mg/ml in buffer E (100mM Tris, pH 8,
50mM MgCl2) after ethanol precipitation.
The crude tRNA was then separated by two sequential
anion exchange HPLC puriﬁcations using a DNAPac
PA100 22 250mm column (Dionex) and a Merck
Hitachi Lachrom system. The ﬁrst puriﬁcation was done
in buffer F (100mM NaOAc, pH 5.0, 50mM MgCl2) with
a gradient of 205–210mM NaCl, followed by concentra-
tion of the tRNA using an Amicon Ultra 10000 MWCO
centrifugal ﬁlter (Millipore) and a further puriﬁcation in
buffer E using a gradient of 205–215mM NaCl The
puriﬁed tRNA was exchanged into buffer E and stored
at  20 C. To obtain nm
5s
2U-containing tRNA, the
cmnm
5s
2U-containing tRNA after pH 5 puriﬁcation
(400mg) was incubated with MnmC (40mg) in 1ml of
buffer G (50mM Tris, 20mM NH4Cl) at 37 C for 1h
before the pH 8 puriﬁcation. For mnm
5s
2U-containing
tRNA, the same procedure was carried out using 100mg
cmnm
5s
2U-tRNA and 10mg MnmC with the addition of
SAM (ﬁnal conc. 800mM).
Characterization of tRNA
The puriﬁed tRNA was analysed by digestion with
RNases A or T1, followed by matrix-assisted laser desorp-
tion/ionization-mass spectrometry (MALDI-MS) (24).
For identiﬁcation of pseudouridine bases, tRNA (2mM)
and acrylonitrile (1.8M) were initially dissolved in
TEA-AcOH buffer (0.98M), ethanol (36%) at a total
volume of 34ml, incubated at 70 C for 2h, then
lyophilized, redissolved in water and exchanged into
pure water using a centrifugal ﬁlter.
RNase digests were performed by incubation of tRNA
(0.2mg) with RNase A (0.1mg, Fermentas) or RNase T1
(1U, Ambion) in 3mg/ml 3-HPA, 1% acetonitrile at a
total volume of 3mla t3 7  C for 2h (for RNase A) or 7h
(for RNase T1). The hydrolysed tRNA was desalted three
times using a 0.025mM drop dialysis ﬁlter (Millipore) then
0.5ml of the solution was mixed with 0.5ml of matrix
(0.6M 3-HPA, 32mM picolinic acid, 18mM diammonium
citrate, 10% acetonitrile) on a MALDI sample plate and
allowed to dry. MALDI-TOF MS was performed using a
Bruker Autoﬂex II in negative mode with 19kV and 16kV
ionization source voltages, 8.55kV lens voltage, 20kV re-
ﬂector voltage and 200ns pulsed ion extraction. Masses
were externally calibrated using oligonucleotides of
known sequence, or internally calibrated using invariant
tRNA fragments from the sample (e.g. for accurate
analysis of the anticodon–stem loop fragment).
Assay of MnmC
For assay of the FAD-dependent MnmC activity, the fol-
lowing ﬁnal reaction mixture was used: cmnm
5s
2U-
containing tRNA (0.13–2.0mM), MnmC (1.7nM), Tris
(60mM, pH 8.0), NH4Cl (20mM) KCl (2.5mM), MgCl2
(0.65mM), b-mercaptoethanol (0.15mM), glycerol
(0.5%), bovine serum albumin (BSA; 5mg/ml) [note:
4820 Nucleic Acids Research, 2011,Vol.39, No. 11KCl, b-mercaptoethanol, glycerol and BSA were only
present as they were used in the enzyme storage buffer].
All components except the enzyme were assembled on ice,
then preincubated at 37 C in a water bath for 3min. The
enzyme (in buffer D plus 0.1mg/ml BSA) was then added,
and aliquots of at least 20ng tRNA were removed within
the ﬁrst 5min of reaction, diluted at least 2 with buffer F
then injected onto a DNAPac PA100 4 250mm column
(Dionex) and analysed in buffer E with a gradient of
175–180mM NaCl. Reaction volumes were typically
40ml. Each assay was carried out in triplicate.
For assay of the SAM-dependent MnmC activity, the
following ﬁnal reaction mixture was used: nm
5s
2U con-
taining tRNA (25–400nM), MnmC (42pM), SAM
(500mM), Tris (60mM, pH 8.0), NH4Cl (20mM) KCl
(2.5mM), MgCl2 (0.65mM) b-mercaptoethanol
(0.15mM), glycerol (0.5%), ethanol (0.6%), BSA
(5mg/ml) [note: KCl, b-mercaptoethanol, glycerol and
BSA and ethanol were only present as they were used in
the enzyme or SAM storage buffers]. The reaction was
performed as described for the FAD-dependent activity
above, using an HPLC gradient of 160–165mM NaCl
and typical reaction volumes of 160ml.
Reaction progress was calculated from the ratio of the
areas of the product and starting material UV absorbance
peaks (260nm) in the HPLC chromatograms. In the case
of the SAM-dependent reaction, the product and starting
material peaks overlapped, and were deconvoluted using
the eXPFit14 add-in (www.chem.qmul.ac.uk/software/
eXPFit.htm) for Microsoft Excel. Reaction progress was
then plotted versus time, and the linear slope of each plot
measured as the initial reaction rate at the corresponding
substrate concentration. Michaelis–Menten curves were
ﬁtted to the initial rate versus [S] data using the EZ-Fit5
program (Perrella Scientiﬁc).
To ensure that the UV absorbance data gave a linear
response for the product and substrate peak areas, cali-
bration injections were performed at a range of concen-
trations of cmnm
5s
2U, nm
5s
2U and mnm
5s
2U containing
tRNA. To ensure that the SAM concentration of 500mM
was saturating, preliminary nm
5s
2U to mnm
5s
2U assays
were carried out with a range of SAM concentrations.
SAM concentrations from 100 to 1000mM were found
to give similar reaction rates, indicating that the KM for
SAM is much <500mM.
Bacterial growth rate experiments
Bacterial strains were obtained from the Keio collection of
E. coli knockouts (obtained from the NBRP-E.coli at
NIG). Growth rates of the wild-type (BW25113) and
MnmC (JW5380) strains were measured at 37 Ci n
rich (LB) medium by recording optical densities at
600nm (OD600) at various time points. Pre-cultures were
initially grown exponentially for several generations
before dilution into fresh medium for data collection.
Each strain was grown in triplicate under identical condi-
tions. Growth rates were calculated by ﬁtting an exponen-
tial curve of the type y=Ae
kt.
RESULTS
Preparation of selectively under-modiﬁed tRNA
Glu
substrates for MnmC
In order to prepare selectively under-modiﬁed tRNA
Glu,
we assembled a tRNA overexpression system (25) using an
E. coli strain that lacks the MnmC gene. As the expression
construct, the E. coli tRNA
Glu gene was cloned into a
protein expression plasmid (pSGAT2) containing a T7
promoter for inducible expression. An additional T7
promoter was added directly 50 to the tRNA gene in
order to expedite tRNA processing (as the RNA tran-
scripts from this promoter should begin at the ﬁrst
position of the tRNA and therefore not require enzymatic
50-cleavage). To obtain an expression strain lacking
MnmC, we used the recombineering method (23) to
replace the MnmC gene in T7 expression cells with an
antibiotic resistance cassette. The tRNA expression
plasmid was then used to transform MnmC cells, from
which tRNA
Glu was expressed and isolated by phenol ex-
traction (6). The major tRNA ‘modivariants’ (10)
obtained were then separated by anion-exchange HPLC
(Figure 1a and b) then partially sequenced by
MALDI-MS analysis of RNase digests (Figure 2). All
major peaks in the HPLC chromatogram were found to
be tRNA
Glu based on this MALDI sequencing
(Figure 2a–c and Supplementary Figure S1), showing
that a very high level of expression was sustained by the
cells. A single modivariant (tRNA 1, Figure 1a and c) was
found to contain the desired cmnm
5s
2U modiﬁcation
(Figure 2c) as well as the other expected mass-detectable
tRNA
Glu modiﬁcations (T and m
2A, Figure 2a–c). The
presence of the two expected pseudouridine () nucleo-
tides in this tRNA was then conﬁrmed by reaction with
acrylonitrile followed by RNase/MS analysis
(Supplementary Figure S2) (24). The other modivariants
obtained lacked anticodon–stem loop modiﬁcations
(Supplementary Figure S1), as labelled in Figure 1c.
The puriﬁed cmnm
5s
2U-containing tRNA 1 was reacted
with puriﬁed recombinant MnmC (21) in the absence or
presence of the SAM cofactor to give nm
5s
2Uo r
mnm
5s
2U-containing tRNA, respectively (tRNA 5 and
6, Figure 1c). These tRNA products were further
puriﬁed by anion-exchange HPLC and analysed by
MALDI-MS of RNase T1 digests of the tRNA
products. Mass peaks corresponding to the anticodon–
stem loop fragments conﬁrmed the identity of each
tRNA (Figure 2d and e). High purity of the tRNAs 1
and 5 was determined from the lack of contaminating
under-modiﬁed fragments in MALDI-MS spectra, the
single major HPLC peak detected for each tRNA, and
the observed complete reaction with MnmC as measured
by HPLC.
Development of an HPLC-based assay for both
activities of MnmC
Anion-exchange HPLC of the cmnm
5s
2U- mnm
5s
2U- and
nm
5s
2U-containing tRNAs showed that each elutes at a
different retention time (Figure 3a and b), allowing an
HPLC-based assay to be used to measure both activities
Nucleic Acids Research, 2011,Vol.39, No. 11 4821of the enzyme. As full separation of tRNA 5 and 6 was not
obtained, a computational peak deconvolution was
employed to calculate the area of each peak (Figure 3b).
Preliminary studies conﬁrmed the linear response of the
areas of the product and substrate peaks, and the approxi-
mate saturating concentration of the SAM cofactor
( 100mM). Subsequently, steady-state kinetic assays for
each reaction step were carried out. The conditions for
each assay were chosen to be similar in order to
compare kinetic constants, and were based on conditions
known to optimize enzyme activity (20) with the addition
of MgCl2 to stabilize tRNA (26). Rate versus substrate
concentration curves are shown in Figure 3c and d.
Fitting a rectangular hyperbola to these curves gives the
Michaelis–Menten constants shown in Table 1. The Km
for the second reaction is substantially lower ( 9-fold)
than that of ﬁrst reaction, and the kcat constant is not
signiﬁcantly different. This shows that the enzyme binds
the second substrate (tRNA 5) tighter than the ﬁrst
(tRNA 1). This clearly will result in a higher rate of
reaction for the second step, or similar rates at very high
substrate concentrations where the kcat constant becomes
dominant. The kcat/Km value, a general indicator of
activity, is correspondingly eight times higher for the
second reaction step, showing substantially higher
activity at intermediate substrate concentrations.
To further support our idea that partially
hypermodiﬁed nucleosides negatively affect translation
processes, we measured the growth rate of a well-deﬁned
MnmC knockout strain from the Keio collection of E. coli
knockouts (Figure 4). Exponential ﬁts to the growth
curves of the MnmC and wild-type strains reveal a
larger growth constant, k, for the wild-type strain. As
the knockout strain is expected to contain the cmnm
5
Figure 1. Overexpressed tRNA
Glu from a MnmC E. coli strain. (a) HPLC of total extracted tRNA. HPLC buffers: 100mM Tris pH 8,
50!150mM MgCl2. The four major modivariants are labelled 1–4. Each was isolated by HPLC for subsequent MS analysis of modiﬁed nucleo-
sides. (b) Representative puriﬁed tRNA (tRNA 5, see below) after anion-exchange puriﬁcations at pH 5 and 8. HPLC buffers: 100mM Tris pH 8,
50mM MgCl2,0 !500mM NaCl. [Note: The MgCl2 and NaCl gradients in (a) and (b) were used interchangeably for analytical purposes] (c)
Diagrams showing the modiﬁed nucleosides present in tRNAs 1–5 and those present in tRNAs 5 and 6, the products of reaction of tRNA 1 with
MnmC (see below). Nucleosides labelled in red (or orange or yellow) were identiﬁed by MS (Figure 2 and Supplementary Figure S1). The presence of
 nucleosides labelled in grey was not conﬁrmed. tRNA 1 contains cmnm
5s
2U34 and all other expected modiﬁcations, while tRNA 2–4 are less fully
modiﬁed at anticodon–stem loop postions as shown. The nm
5s
2U and mnm
5s
2U modiﬁcations obtained by reaction with MnmC are shown in orange
and yellow, respectively, to differentiate from cmnm
5s
2U.
4822 Nucleic Acids Research, 2011,Vol.39, No. 11Figure 2. MALDI-MS spectra of RNase digests of tRNA 1, 5 and 6. (a) RNase A digest of tRNA 1 (cmnm
5s
2U-tRNA
Glu). (b) RNase T1 digest of
tRNA 1. (c) Expanded section of (b) showing the anticodon–stem loop fragment of tRNA 1. Extra peaks are assigned as follows. a: 3165.5,
Fragment A [AAUCCCCUAGcp (cp=cyclic phosphate)]; b: 3182.9, Fragment B (AAUCCCCUAGp); c: 3203.7, Fragment A – H+K and
Fragment B – H+Na; d: 3221.3, Fragment B – H+K; e: 3235.6, Fragment C (CCCUcmnm
5s
2UUCm
2ACGcp); f: 3242.4, Fragment A –
2H+2K; g: 3258.4, Fragment B – 2H+2K; h: 3274.4, Fragment C – H+K and Fragment D (CCCUcmnm
5s
2UUCm
2ACGp) – H+Na; i:
3290.9, Fragment D – H+K; j: 3296.0, Fragment B – 3H+3K. (d) Section of a RNase T1 digest of tRNA 5 (nm
5s
2U-tRNA
Glu) showing the
nm
5s
2U-containing fragment. Extra peaks are assigned as follows. a: 3165.3, Fragment A (AAUCCCCUAGcp); b: 3177.8, Fragment E
(CCCUnm
5s
2UUCm
2ACGcp), c: 3182.9, Fragment B (AAUCCCCUAGp); d: 3204.2, Fragment B – H+Na; e: 3215.8, Fragment E – H+K; f:
3221.2, Fragment B – H+K; g: 3233.5, Fragment F (CCCUnm
5s
2UUCm
2ACGp) – H+K; h: 3243.3, Fragment B – 2H+Na+K; i: 3258.5,
Fragment B – 2H+2K; j: 3270.1, Fragment F – 2H+2K; k: 3296.1, Fragment B – 3H+3K; l: 3307.8, Fragment F – 3H+3K. (e) Section of an
RNase T1 digest of tRNA 6 (mnm
5s
2U-tRNA
Glu) showing the mnm
5s
2U-containing fragment. Extra peaks are assigned as follows. a: 3165.4,
Fragment A (AAUCCCCUAGcp); b: 3182.9, Fragment B (AAUCCCCUAGp); c: 3191.0, Fragment G (CCCUmnm
5s
2UUCm
2ACGcp); d: 3204.9,
Fragment B – H+Na; e: 3221.0, Fragment B – H+K; f: 3229.3, Fragment G – H+K; g: 3246.4, Fragment H (CCCUmnm
5s
2UUCm
2ACGp) –
H+K; h: 3258.9, Fragment B – 2H+2K; i: 3267.3, Fragment G – 2H+2K; j: 3283.9, Fragment H – 2H+2K; k: 3296.5, Fragment B – 3H+3K; l:
3306.7, Fragment A – 3H+3K; m: 3322.0, Fragment H – 3H+3K; n: Fragment B – 4H+4K. The tRNA fragments analysed in (a) and (b) are
labelled with mass and sequence on each spectrum, and coloured in red on each corresponding tRNA diagram. The data in (c)–(e) are calibrated to
the constant fragment B (AAUCCCCUAGp, 3182.9) to allow accurate determination of the variable anticodon fragment.
Nucleic Acids Research, 2011,Vol.39, No. 11 4823modiﬁcation in place of mnm
5, the result shows that this
cmnm
5 under-modiﬁcation is detrimental to cell growth.
DISCUSSION
The MnmC enzyme catalyses the ﬁnal two steps of the
biosynthesis of the mnm
5(s
2)U34 nucleoside in tRNA.
The mnm
5 biosynthesis pathway seems to be tuned to
give only the fully modiﬁed residue, in particular
avoiding nm
5 under-modiﬁcation [cmnm
5s
2U has been
detected in vivo (8); however, it is not clear whether this
is due to under-modiﬁcation or the natural presence of
cmnm
5 in certain tRNAs]. The biosynthetic machinery
could be regulated in a number of ways, for example by
selective degradation of partially modiﬁed tRNA (11),
controlled expression [or compartmentalization, in eu-
karyotes (12)] of particular modifying enzymes or by op-
timization of enzyme activities and speciﬁcities. This study
reveals that the two transformations catalysed by MnmC
are regulated by enzyme kinetics, as the second substrate is
bound tighter than the ﬁrst. Even at relatively high sub-
strate concentrations ( 3mM), the two reactions would be
performed at similar rates, resulting in a relatively low
concentration of the partially modiﬁed intermediate.
Degradation of the under-modiﬁed tRNA cannot be
ruled out as an additional mechanism; however, this
seems unlikely given the existing kinetic control and the
Figure 3. HPLCs and Michaelis–Menten plots for each MnmC catalysed reaction. (a) Representative HPLC showing complete separation of tRNA
1 from tRNA 5. HPLC gradient: 100mM Tris, 50mM MgCl2, 175!180mM NaCl over 1!20min. (b) Representative HPLC showing partial
separation of tRNA 5 from tRNA 6, and calculated peaks for each tRNA. HPLC gradient: 100mM Tris, 50mM MgCl2, 160!165mM NaCl over
1!30min. (c) Michaelis–Menten plot for the FAD-dependent cmnm
5s
2U!nm
5s
2U demodiﬁcation. (d) Michaelis–Menten plot for the
SAM-dependent nm
5s
2U!mnm
5s
2U methylation. Rates in (c) and (d) represent the amount of substrate formed in a 40ml reaction per minute
per milligram enzyme.
Table 1. Michaelis–Menten constants for each MnmC catalysed
reaction
Reaction Km (nM) kcat (s
 1) kcat/Km (mM
 1 s
 1)
cmnm
5s
2U!nm
5s
2U 600±200 0.34±0.04 0.56
nm
5s
2U!mnm
5s
2U 70±40 0.31±0.05 4.5
4824 Nucleic Acids Research, 2011,Vol.39, No. 11inefﬁciency associated with degradation of a highly
modiﬁed tRNA.
In terms of the applicability of our in vitro study to
in vivo enzyme activity, several aspects need to be con-
sidered. It is possible that the modiﬁcation reactions are
affected in vivo by other cellular components. Importantly,
Mg
2+ and NH+
4 concentrations were reported previously
to affect enzyme activity. However, this is unlikely to sub-
stantially change the results reported here, as both
activities of MnmC were reported to be similarly
affected by changes in the concentrations of these ions
(20). Intracellular SAM concentrations are reported to
be similar to those used in our assay (27), so our result
is likely to be relevant in this respect. Other modifying
enzymes have been found to be dependent on the state
of tRNA processing, such as TilS, which modiﬁes
tRNA
Ile2 at a precursor stage (28). None of the cmnm
5-
or mnm
5-containing tRNA obtained in the tRNA
Glu
overexpressions here and in a previous study (10) was
found to lack other modiﬁcations, implying that MnmC
acts on tRNA at a late stage of processing. Therefore, it is
likely that our substrates represent those normally
modiﬁed by MnmC.
The fact that the mnm
5(s
2)U pathway is tuned to give
full modiﬁcation suggests that the partially modiﬁed nu-
cleoside (particularly nm
5(s
2)U) is particularly detrimental
to translation. Our result that MnmC E. coli, which
contain cmnm
5(s
2)U instead of mnm
5(s
2)U, grows signiﬁ-
cantly slower than wild-type E. coli, supports this
proposal. It is likely that the observed slow growth of
the MnmC knockout is a result of disruption of the
reported ﬁne tuning of A and G wobble pairing with
mnm
5s
2U (14). Interestingly, some species completely
lack an MnmC-type modiﬁcation and instead use
cmnm
5s
2U in the 34 position of tRNA e.g. Bacillus
subtilis (3) and Saccharomyces cerevisiae (29). It is
unclear at this stage as to why other organisms expend
energy to further modify cmnm
5s
2U to mnm
5s
2U.
The assay method reported here is a general approach
that should be applicable to comparative assay of most
tRNA modiﬁcations. Although a number of very effective
radioactivity-based assays have been reported (20,30),
these require speciﬁc radioactive substrates and are not ap-
plicable to modiﬁcations for which no radioactive incorp-
oration can be measured (e.g. the cmnm
5s
2U!nm
5s
2U
demodiﬁcation). Analysis of reaction progress by
reverse-phase HPLC of full RNase digests is also
possible (18) but is complicated by the extra digestion
step and the requirement for quantiﬁcation standards.
Our analysis of intact tRNA using HPLC also allows veri-
ﬁcation of tRNA stability during reaction, which is often
not taken into account (31). We believe our general
approach will allow better comparison of the activities
of tRNA-modifying enzymes in future studies.
In summary, we reveal that the full modiﬁcation of the
mnm
5s
2U tRNA modiﬁcation is regulated by kinetic
tuning of the activities of the MnmC enzyme. Our
method represents a general approach to the comparative
analysis of tRNA-modifying enzymes, and should be ap-
plicable to the study of other modiﬁcation pathways. With
the methods for selective preparation and assay of
modiﬁed tRNA developed in this article, future studies
will be carried out to further elucidate the regulation of
tRNA modiﬁcation and the impact of partial
hypermodiﬁcation on genetic processes.
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